#Followers1 .followers-grid, #Followers1 .followers-count { display: none !important; }

Saturday, 10 May 2025

Barrett’s Oesophagus: Pathophysiology & Clinical Implications

Barrett’s oesophagus is a pre-malignant condition characterised by intestinal metaplasia of the normal stratified squamous epithelium in the oesophagus. 




This transformation occurs as a defensive response to chronic acid exposure, but paradoxically increases the risk of oesophageal adenocarcinoma.

🚨 How Does Barrett’s Oesophagus Develop?

The main driver of Barrett’s oesophagus is chronic gastro-oesophageal reflux disease (GORD). Repeated exposure to gastric acid, pepsin, and bile salts induces cellular changes in the oesophageal lining.

πŸ”Ή Initial Oesophageal Injury

  •  Prolonged acid exposure leads to chronic inflammation, causing epithelial stress and increased cell turnover.
  •  Epithelial damage disrupts tight junctions, making the mucosa more susceptible to injury.
  •  Inflammatory cytokines (IL-1Ξ², TNF-Ξ±, IL-6) and oxidative stress drive cellular adaptation.

πŸ”Ή Metaplastic Transformation

  •  The normal stratified squamous epithelium cannot withstand persistent acidic stress, leading to cellular reprogramming.
  •  Basal stem cells differentiate into columnar epithelium, resembling intestinal mucosa, complete with goblet cells (hallmark of Barrett’s oesophagus).
  •  This adaptive change is mediated by transcription factors such as CDX2, which promotes intestinal-type differentiation.

πŸ”Ή Progression Toward Dysplasia & Malignancy

  •  Over time, genetic and epigenetic mutations accumulate, increasing the risk of low-grade and high-grade dysplasia.
  •  TP53 mutations and chromosomal instability promote oncogenesis.
  •  Dysplastic changes create a precursor lesion for oesophageal adenocarcinoma—a major concern in Barrett’s patients.

🩸 Histological Features of Barrett’s Oesophagus

✅ Normal Oesophagus: Stratified squamous epithelium, resilient against mechanical stress but vulnerable to acid.

✅ Barrett’s Oesophagus: Columnar epithelium with goblet cells, resembling intestinal mucosa.

✅ Dysplasia (Pre-Malignant): Architectural disorganisation, nuclear atypia, loss of cellular polarity.

✅ Adenocarcinoma: Invasive tumour formation, often arising from dysplastic Barrett’s segments.












πŸ“Š Risk Factors & Disease Progression

πŸ”Ί Chronic GORD (>5 years) → Persistent acid exposure

πŸ”Ί Obesity → Increased intra-abdominal pressure worsens reflux

πŸ”Ί Smoking & Alcohol → Synergistic effects promoting oxidative damage

πŸ”Ί Genetic Predisposition → Familial clustering suggests inherited susceptibility

πŸ”Ί Male Sex & Age >50 → Higher incidence in older males

πŸ›‘ Clinical Implications & Screening Guidelines

πŸš‘ Barrett’s oesophagus is a major risk factor for oesophageal adenocarcinoma, but progression varies.

✔ Patients with long-segment Barrett’s (>3cm metaplasia) have higher malignant potential.

✔ Endoscopic surveillance (± biopsies) recommended every 3-5 years for non-dysplastic Barrett’s.

✔ If dysplasia is detected, interventions like radiofrequency ablation or endoscopic mucosal resection may be necessary.













πŸ’‘ Key Takeaway

Barrett’s oesophagus starts as an adaptive process, but its progression toward dysplasia and adenocarcinoma makes it a clinically significant condition. Early recognition, surveillance, and intervention are crucial in preventing malignant transformation.




No comments:

Post a Comment

↑ Back to top